163 related articles for article (PubMed ID: 15336594)
21. Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis.
Gallegos-Orozco JF; E Yurk C; Wang N; Rakela J; Charlton MR; Cutting GR; Balan V
Am J Gastroenterol; 2005 Apr; 100(4):874-8. PubMed ID: 15784035
[TBL] [Abstract][Full Text] [Related]
22. CFTR mutations impart elevated immune reactivity in a murine model of cystic fibrosis related diabetes.
Stalvey MS; Brusko TM; Mueller C; Wasserfall CH; Schatz DA; Atkinson MA; Flotte TR
Cytokine; 2008 Oct; 44(1):154-9. PubMed ID: 18778952
[TBL] [Abstract][Full Text] [Related]
23. Outcome of intracytoplasmic sperm injection for a couple in which the man is carrier of CFTR p.[R74W;V201M;D1270N] and p.P841R mutations and his spouse a heterozygous carrier of p.F508del mutation of the cystic fibrosis transmembrane conductance regulator gene.
Brugnon F; Bilan F; Heraud MC; Grizard G; Janny L; Creveaux I
Fertil Steril; 2008 Nov; 90(5):2004.e23-6. PubMed ID: 18703181
[TBL] [Abstract][Full Text] [Related]
24. Elevated hepatic SULT1E1 activity in mouse models of cystic fibrosis alters the regulation of estrogen responsive proteins.
Li L; Falany CN
J Cyst Fibros; 2007 Jan; 6(1):23-30. PubMed ID: 16798114
[TBL] [Abstract][Full Text] [Related]
25. Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammation.
Saadane A; Soltys J; Berger M
J Allergy Clin Immunol; 2006 May; 117(5):1163-9. PubMed ID: 16675347
[TBL] [Abstract][Full Text] [Related]
26. Distinct pattern of lung gene expression in the Cftr-KO mice developing spontaneous lung disease compared with their littermate controls.
Guilbault C; Novak JP; Martin P; Boghdady ML; Saeed Z; Guiot MC; Hudson TJ; Radzioch D
Physiol Genomics; 2006 Apr; 25(2):179-93. PubMed ID: 16418321
[TBL] [Abstract][Full Text] [Related]
27. Sendai virus-mediated CFTR gene transfer to the airway epithelium.
Ferrari S; Griesenbach U; Iida A; Farley R; Wright AM; Zhu J; Munkonge FM; Smith SN; You J; Ban H; Inoue M; Chan M; Singh C; Verdon B; Argent BE; Wainwright B; Jeffery PK; Geddes DM; Porteous DJ; Hyde SC; Gray MA; Hasegawa M; Alton EW
Gene Ther; 2007 Oct; 14(19):1371-9. PubMed ID: 17597790
[TBL] [Abstract][Full Text] [Related]
28. Mutation analysis of CFTR gene in 70 Iranian cystic fibrosis patients.
Alibakhshi R; Zamani M
Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):3-8. PubMed ID: 17242497
[TBL] [Abstract][Full Text] [Related]
29. Instability of the insertional mutation in CftrTgH(neoim)Hgu cystic fibrosis mouse model.
Charizopoulou N; Jansen S; Dorsch M; Stanke F; Dorin JR; Hedrich HJ; Tümmler B
BMC Genet; 2004 Apr; 5():6. PubMed ID: 15102331
[TBL] [Abstract][Full Text] [Related]
30. Direct interaction of a small-molecule modulator with G551D-CFTR, a cystic fibrosis-causing mutation associated with severe disease.
Pasyk S; Li C; Ramjeesingh M; Bear CE
Biochem J; 2009 Feb; 418(1):185-90. PubMed ID: 18945216
[TBL] [Abstract][Full Text] [Related]
31. Finally, mice with CF lung disease.
Frizzell RA; Pilewski JM
Nat Med; 2004 May; 10(5):452-4. PubMed ID: 15122239
[No Abstract] [Full Text] [Related]
32. Rectal potential difference and the functional expression of CFTR in the gastrointestinal epithelia in cystic fibrosis mouse models.
Weiner SA; Caputo C; Bruscia E; Ferreira EC; Price JE; Krause DS; Egan ME
Pediatr Res; 2008 Jan; 63(1):73-8. PubMed ID: 18043508
[TBL] [Abstract][Full Text] [Related]
33. Enhanced F508del-CFTR channel activity ameliorates bone pathology in murine cystic fibrosis.
Le Henaff C; Haÿ E; Velard F; Marty C; Tabary O; Marie PJ; Jacquot JP
Am J Pathol; 2014 Apr; 184(4):1132-1141. PubMed ID: 24529904
[TBL] [Abstract][Full Text] [Related]
34. Fat absorption in cystic fibrosis mice is impeded by defective lipolysis and post-lipolytic events.
Bijvelds MJ; Bronsveld I; Havinga R; Sinaasappel M; de Jonge HR; Verkade HJ
Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G646-53. PubMed ID: 15528257
[TBL] [Abstract][Full Text] [Related]
35. Iron Homeostasis and Inflammatory Status in Mice Deficient for the Cystic Fibrosis Transmembrane Regulator.
Deschemin JC; Allouche S; Brouillard F; Vaulont S
PLoS One; 2015; 10(12):e0145685. PubMed ID: 26709821
[TBL] [Abstract][Full Text] [Related]
36. [Genotype and phenotype of gastrointestinal symptoms analysis in children with cystic fibrosis].
Iwańczak F; Smigiel R; Stawarski A; Pawłowicz J; Stembalska A; Mowszet K; Sasiadek M
Pol Merkur Lekarski; 2005 Feb; 18(104):205-9. PubMed ID: 17877132
[TBL] [Abstract][Full Text] [Related]
37. Rescue of functional delF508-CFTR channels in cystic fibrosis epithelial cells by the alpha-glucosidase inhibitor miglustat.
Norez C; Noel S; Wilke M; Bijvelds M; Jorna H; Melin P; DeJonge H; Becq F
FEBS Lett; 2006 Apr; 580(8):2081-6. PubMed ID: 16546175
[TBL] [Abstract][Full Text] [Related]
38. Single-dose lentiviral gene transfer for lifetime airway gene expression.
Stocker AG; Kremer KL; Koldej R; Miller DS; Anson DS; Parsons DW
J Gene Med; 2009 Oct; 11(10):861-7. PubMed ID: 19634193
[TBL] [Abstract][Full Text] [Related]
39. Segregation analysis in cystic fibrosis at-risk family demonstrates that the M348K CFTR mutation is a rare innocuous polymorphism.
D'Apice MR; Gambardella S; Russo S; Lucidi V; Nardone AM; Pietropolli A; Novelli G
Prenat Diagn; 2004 Dec; 24(12):981-3. PubMed ID: 15614862
[TBL] [Abstract][Full Text] [Related]
40. Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation.
Pashuck TD; Franz SE; Altman MK; Wasserfall CH; Atkinson MA; Wronski TJ; Flotte TR; Stalvey MS
Pediatr Res; 2009 Mar; 65(3):311-6. PubMed ID: 19047917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
